Alendronic acid osteoporosis drug

Alendronic acid osteoporosis drug

M625/1492 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 31.4MB

Downloadable file size: 2.4MB

Price image Pricing

Please login to use the price calculator


Caption: Alendronic acid osteoporosis drug. Packaging and blisterpack for the osteoporosis drug alendronic acid. This drug is used to treat and prevent osteoporosis in post-menopausal women. It belongs to a class of drugs called bisphosphonates. It inhibits the action of bone cells that degrade and reabsorb bone (osteoclasts), therefore slowing the loss of bone mass. One tablet is taken once a week. It is important to take alendronic acid while upright and with plenty of water as it can cause inflammation and ulceration of the oesophagus.

Release details: Model release not required. Property release not required.

Keywords: alendronic acid, bisphosphonate, blisterpack, box, brittle bone disease, drug, healthcare, medical, medication, medicine, osteoporosis, packaging, pharmaceutic, pharmaceutical, pharmacological, pharmacology, post-menopausal, preventative, prevention, still life, still-life, tablet, tablets, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.